drugset / Trial / NCT00000339

Infusion Laboratory: Protocol 3 (Risperidone) - 4

NCT00000339

Phase 1 Unknown 13 enrolled National Institute on Drug Abuse (NIDA)
CrossoverSingle-blindTreatment

Summary

The purpose of this study is to evaluate clinical safety issues pertaining to risperidone, to cocaine and to its interaction, and to determine how pretreatment with risperidone modifies the subjective as well as physiological effects of cocaine.

Timeline

Start
1996-06
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Risperidone Other / unclassified